| Code | 40832 | ||||||||||
| MA number | EU/1/03/271/002 | ||||||||||
| Product Form: | plv iol 1x500 IU+1x5 ml solv. (liek.inj.skl.+liek.inj.skl.+ pom.na rekonšt.) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU | ||||||||||
| Therapeutic Class: | 16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | glass vial | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 8(3) application - known active substance |
| MA issued: | 02.03.2004 |
| SmPC + PL: |
European Medicines Agency's database
|
| Dokument: |
DHPC_BAXJECT II_BAXJECT II Hi-Flow_10.08.2023.pdf
|
| Safety feature | Yes |
| Data update: | 17.04.2020 |
